Related Experiment Video
Updated: Oct 16, 2025
07:33
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
35.4K
GPR55-Mediated Effects in Colon Cancer Cell Lines
Carina Hasenoehrl1, David Feuersinger1, Melanie Kienzl1,2
1Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Medical Cannabis and Cannabinoids
|October 22, 2021
Summary
GPR55 receptor overexpression enhances colon cancer cell growth. While not affecting native cells, signaling in overexpressing cells impacts ERK1/2 phosphorylation and proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The G protein-coupled receptor GPR55 and its ligand L-α-lysophosphatidyl-inositol (LPI) are implicated in various cancers.
- Elevated LPI levels and a proliferation-enhancing effect of GPR55 have been observed in cancer patients and cell lines.
Purpose of the Study:
- To investigate the role of GPR55 signaling in colon cancer cell proliferation.
- To determine if GPR55 manipulation affects colon cancer cell growth.
Main Methods:
- Cell viability assays were used to assess proliferation.
- Western blotting was employed to analyze protein levels, specifically phosphorylated ERK1/2.
- Stable GPR55 overexpression and pharmacological GPR55 modulation were utilized.
Main Results:
- Stable overexpression of GPR55 conferred a growth advantage to SW480 colon cancer cells.
- Pharmacological manipulation of GPR55 did not affect the proliferation of native colon cancer cell lines.
- GPR55 signaling modulated ERK1/2 phosphorylation in GPR55-overexpressing cells upon treatment with LPI (agonist) and CID16020046 (antagonist).
Conclusions:
- GPR55 overexpression leads to a growth advantage in colon cancer cells.
- GPR55 signaling appears constitutively active in overexpressing cells, influencing ERK1/2 phosphorylation and proliferation.
- These findings suggest a potential role for GPR55 in colon cancer progression, particularly in cells with elevated receptor levels.
